Skip to main content
Top
Literature
1.
go back to reference Uraz S, Aygun C, Sonsuz A, Ozbay G (2005) Serum iron levels and hepatic iron overload in nonalcoholic steatohepatitis and chronic viral hepatitis. Dig Dis Sci 50:964–969PubMedCrossRef Uraz S, Aygun C, Sonsuz A, Ozbay G (2005) Serum iron levels and hepatic iron overload in nonalcoholic steatohepatitis and chronic viral hepatitis. Dig Dis Sci 50:964–969PubMedCrossRef
2.
go back to reference Duseja A, Das R, Nanda M, Das A, Grewal G, Chawla Y (2005) Nonalcoholic steatohepatitis in Asian Indians is neither associated with iron overload nor with HFE gene mutations. World J Gastroenteorol 11:393–395 Duseja A, Das R, Nanda M, Das A, Grewal G, Chawla Y (2005) Nonalcoholic steatohepatitis in Asian Indians is neither associated with iron overload nor with HFE gene mutations. World J Gastroenteorol 11:393–395
3.
go back to reference George DK, Goldwurm S, MacDonald GA, Cowley LL, Walker NI, Ward PJ, Jaswinska EC, Powell LW (1998) Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis. Gastroenterology 114:311–318PubMedCrossRef George DK, Goldwurm S, MacDonald GA, Cowley LL, Walker NI, Ward PJ, Jaswinska EC, Powell LW (1998) Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis. Gastroenterology 114:311–318PubMedCrossRef
4.
go back to reference Fargion S, Mattioli M, Fracanzani AL, Sampietro M, Tavazzi D, Focionai P, Taioli E, Valenti L, Fiorelli G (2001) Hyperferritinemia, iron overload and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis. Am J Gastroenterol 96:2448–2455PubMedCrossRef Fargion S, Mattioli M, Fracanzani AL, Sampietro M, Tavazzi D, Focionai P, Taioli E, Valenti L, Fiorelli G (2001) Hyperferritinemia, iron overload and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis. Am J Gastroenterol 96:2448–2455PubMedCrossRef
5.
go back to reference Chitturi S, Weltman M, Farrell GC, McDonald D, Kench J, Liddle C, Samarasinghe D, Lin R, Abeygunasekera S, George J (2002) HFE gene mutations, hepatic iron and fibrosis: Ethnic specific association of NASH with C282Y but not with fibrotic severity. Hepatology 36:142–149PubMedCrossRef Chitturi S, Weltman M, Farrell GC, McDonald D, Kench J, Liddle C, Samarasinghe D, Lin R, Abeygunasekera S, George J (2002) HFE gene mutations, hepatic iron and fibrosis: Ethnic specific association of NASH with C282Y but not with fibrotic severity. Hepatology 36:142–149PubMedCrossRef
6.
go back to reference Garewal G, Das R, Kaur J, Chawla Y (2002) H63D mutation of the HFE gene in beta thalassamia traits does not cause iron overload and the hereditary hemochromatosis in north India is of the non HFE gene type. Blood 100:46 Garewal G, Das R, Kaur J, Chawla Y (2002) H63D mutation of the HFE gene in beta thalassamia traits does not cause iron overload and the hereditary hemochromatosis in north India is of the non HFE gene type. Blood 100:46
Metadata
Title
Serum Iron Levels and Hepatic Iron Overload in Patients with Nonalcoholic Steatohepatitis
Authors
Ajay Duseja
Reena Das
Ashim Das
R. K. Dhiman
Y. K. Chawla
G. Garewal
Publication date
01-10-2006
Published in
Digestive Diseases and Sciences / Issue 10/2006
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-005-9041-9

Other articles of this Issue 10/2006

Digestive Diseases and Sciences 10/2006 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.